0001641241-25-000003.txt : 20250716 0001641241-25-000003.hdr.sgml : 20250716 20250715195225 ACCESSION NUMBER: 0001641241-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250716 DATE AS OF CHANGE: 20250715 EFFECTIVENESS DATE: 20250716 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrus Biotechnology, Inc. CENTRAL INDEX KEY: 0001641241 ORGANIZATION NAME: EIN: 471015686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551903 FILM NUMBER: 251125988 BUSINESS ADDRESS: STREET 1: 3005 1ST AVE STREET 2: SUITE 203 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062586561 MAIL ADDRESS: STREET 1: 3005 1ST AVE STREET 2: SUITE 203 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0708 D LIVE 0001641241 Cyrus Biotechnology, Inc. 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 2062586561 DELAWARE None None Corporation true Lucas Nivon 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Executive Officer Director Mark Benjamin 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Executive Officer Yifan Song 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Chad Waite 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Anthony Manning 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Ramakrishna Satyavolu 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Jason Smith 3005 1ST AVE SUITE 203 SEATTLE WA WASHINGTON 98121 Director Biotechnology Decline to Disclose 06b false 2025-07-01 false true true false 0 1500000 1110000 390000 false 12 0 0 0 false Cyrus Biotechnology, Inc. Lucas Nivon Lucas Nivon Chief Executive Officer 2025-07-15